Status:
UNKNOWN
Navigating the Grey Zone for Antenatal Corticosteroids
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Conditions:
Decision Making, Shared
Pregnancy
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to find out if including a decision support tool in clinical practice guidelines will improve how doctors discuss the option of antenatal corticosteroid treatment with pat...
Eligibility Criteria
Inclusion
- Age 18 year or older.
- Delivered a live neonate at 34+0 to 36+6 weeks of gestation.
- Speaks English.
- Agrees to participate in the questionnaire during their first week post-partum.
- Delivered at one of the six participating obstetrical hospitals.
Exclusion
- None.
Key Trial Info
Start Date :
May 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2024
Estimated Enrollment :
460 Patients enrolled
Trial Details
Trial ID
NCT04792112
Start Date
May 20 2022
End Date
February 1 2024
Last Update
June 2 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Surrey Memorial Hospital
Surrey, British Columbia, Canada, V3V 1Z2
2
BC Women's Hospital
Vancouver, British Columbia, Canada, V6H 3N1